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ABSTRACT
Whereas moderate drinking may have health benefits, excessive alco-
hol consumption causes many important acute and chronic diseases
and is the third leading contributor to preventable death in the United
States. Twin studies suggest that alcohol-consumption patterns are her-
itable (50%); however, multiple genetic variants of modest effect size
are likely to contribute to this heritable variation. Genome-wide asso-
ciation studies provide a tool for discovering genetic loci that contrib-
ute to variations in alcohol consumption. Opportunities exist to
identify susceptibility loci with modest effect by meta-analyzing to-
gether multiple studies. However, existing studies assessed many dif-
ferent aspects of alcohol use, such as typical compared with heavy
drinking, and these different assessments can be difficult to reconcile.
In addition, many studies lack the ability to distinguish between life-
time and recent abstention or to assess the pattern of drinking during
the week, and a variety of such concerns surround the appropriateness
of developing a common summary measure of alcohol intake. Com-
bining such measures of alcohol intake can cause heterogeneity and
exposure misclassification, cause a reduction in power, and affect
the magnitude of genetic association signals. In this review, we discuss
the challenges associated with harmonizing alcohol-consumption data
from studies with widely different assessment instruments, with a par-
ticular focus on large-scale genetic studies. Am J Clin Nutr
2012;95:539–47.
INTRODUCTION
Excessive alcohol consumption is among the leading contributors
to morbidity and mortality worldwide (1). According to the Centers
for Disease Control and Prevention, an average of 79,000 deaths/y in
the United States between 2001 and 2005 were attributable to the
acute and chronic effects of alcohol. Whereas moderate alcohol
consumption (2 drinks/d for men and 1 drink/d for women)
may have some health benefits (2, 3) and disadvantages (4), heavy
drinkers are at increased risk of alcohol-related health conditions
(5, 6) and alcoholism—a serious and fairly common psychiatric
disorder.
Alcohol consumption, including excessive drinking, is influenced
by heritable factors (7–10). Approximately 50% of the variance in
alcohol consumption is attributable to additive genetic factors (11, 12).
A recent genetic study of an Asian population produced highly
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significant results (P , 10258) for SNPs6 neighboring the ALDH
gene, ALDH2 (13), which is involved in alcohol metabolism. Despite
this success, the initial GWAS of alcohol consumption (14) and al-
cohol dependence (15–17) in European-American samples identified
few variants approaching genome-wide significance (P, 5 · 1028).
It is likely that multiple genetic variants of modest effect contribute
to the amount of alcohol consumed, particularly in non-Asian sam-
ples, and we anticipate that extremely large sample sizes will be
needed to have the statistical power to detect them. Such large
sample sizes must be obtained by pooling together data from mul-
tiple studies via meta-analysis—an approach that has yielded con-
siderable success for identifying genetic variants that contribute to
heaviness of cigarette smoking (18–22) and many other phenotypes.
Why are GWAS of alcohol consumption so challenging? One
of the major challenges is phenotype heterogeneity due to dif-
ferences in the ways that studies assess alcohol intake. Individual
studies vary markedly in their objectives for collecting alcohol-
related information and therefore differ in their means of mea-
suring consumption and in the period of interest. For instance,
a study of alcoholism may collect data on a participant’s lifetime
history of heavy drinking, whereas a study of breast cancer may
query respondents on light to moderate levels of alcohol intake to
model its effects on breast cancer (23, 24). This measurement
heterogeneity has significant implications for genetic studies. In this
review, we discuss the genetic underpinnings of alcohol consump-
tion, potential sources of measurement heterogeneity, and the extent
to which differences between studies may affect genetic analyses.
IS ALCOHOL CONSUMPTION HERITABLE?
Alcohol use can be conceptualized as a series of different stages
starting from initiation of use, transitioning to regular use, and
potentially leading to excessive use and alcoholism (25), as shown
in Figure 1. Whereas most aspects of alcohol use are heritable (ie,
influenced, to some degree, by genetic factors) (26), drinking
initiation (or conversely lifetime abstention) tends to be the least
influenced by genetic factors (27–29) and rather appears to be
determined primarily by familial environment (30, 31). For ex-
ample, religion and culture have strong influences on whether and
when a person starts to drink. However, once alcohol use is ini-
tiated, many domains of alcohol use—including current use,
pattern of use, and heaviest use—are influenced by underlying
genetic variation and are heritable (h2 ’ 50%) (8, 32–34). There
is substantial correlation between each of these domains and,
similarly, there is estimated to be overlap of genetic factors, up to
90%, across them (8, 9, 33, 34). Furthermore, these heritable
characteristics of alcohol intake overlap with genetic vulnerability
to alcoholism (genetic correlations 0.9) (8, 32). Environment, of
course, continues to be an important contributor to all these do-
mains, and the context of these environmental influences vary
across the stages (Figure 1).
Understanding the different stages of alcohol use and abuse and
the biases that affect their measurement can aid us in improving
genetic studies. For instance, given the stages of alcohol use and
the proposed common and specific genetic and environmental
influences that contribute to each stage, we anticipate that the
likelihood of identifying genetic influences that contribute to al-
cohol consumption will decrease if lifetime alcohol abstainers are
combined with light drinkers or former drinkers when measures of
alcohol consumption are constructed (eg, a never drinker was
coded as having drunk 0 drinks/wk) (35), because nondrinkers at
a particular time point include both those who have never drank,
thosewho drank a lot in the past but have quit, and thosewho drink
alcohol occasionally but only drink a small amount.
WHAT IS KNOWN ABOUT GENETIC VARIATION IN
ALCOHOL CONSUMPTION?
Genes in the ADH and ALDH complex that regulate alcohol
metabolism (36) are among the most established genetic contributors
to all aspects of drinking. The metabolism of alcohol involves
conversion of alcohol to acetaldehyde, by ADH and then acetal-
dehyde to acetate, by ALDH. Variants in the genes encoding ADH
and ALDH, some of which are more common in Asians (37), are
known to regulate alcohol metabolism to varying degrees. Defects in
this pathway can lead to high concentrations of the intermediate
metabolite acetaldehyde, which causes flushing (facial reddening)
accompanied by nausea, dizziness, and other unpleasant physiologic
symptoms); thus, individuals who experience this reaction are
considerably less likely to continue to drink (38). Although there
are several intriguing polymorphisms in the ADH and ALDH
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gene families, 2 coding SNPs are of note. In the ADH1B gene,
one allele of rs1229984 leads to accelerated oxidation of alcohol
to acetaldehyde; in ALDH2, one allele of rs671 leads to nearly no
activity of the mitochondrial ALDH (36). These polymorphisms
are robustly correlated with alcohol consumption and dependence
(39–41). However, the allele frequencies of the most protective
variants are very low in European populations, which leaves most
of the heritability in these populations to be explained by other
genes. Despite this, a recent study found strong support for the
protective effect of rs1229984 on alcohol dependence in Euro-
peans and African Americans (42).
Many other genes that may be associated with the personality
characteristics of drinkers (eg, impulsivity and disinhibition) and
loss of control and other neurobiological consequences of drinking
(eg, alcohol-induced blackouts and tolerance) are likely to also be
involved (12, 26). Because these genetic variants are likely to
individually exert onlymodest effects on alcohol consumption, it is
a considerable challenge to identify them. Accumulating very large
samples that draw phenotypic and genomic data from multiple
sources provides one such exciting way to address this challenge.
THE ADVANTAGE OF GWAS META-ANALYSIS
How a meta-analysis of GWAS proceeds is outlined in Figure 2.
In addition to harmonizing phenotypes, as is typically performed
in all meta-analyses, genotypes from various platforms also need
to be harmonized, via imputation, to a common scale (eg, Hap-
Map, 1000 Genomes). Three large-scale GWAS meta-analyses
of cigarette smoking have now definitively validated the role of
a missense mutation (rs16969968 or its proxy rs1051730) (43) in
the cluster of CHRNA5-CHRNA3-CHRNB4 genes on chromosome
15 (19, 21, 22). However, to achieve levels of appropriate statis-
tical significance that overcome potential type I error from mul-
tiple comparisons, samples exceeding 40,000 (with the largest
sample exceeding 140,000) were necessary. The success with
GWAS of smoking behavior offers the hope that alcohol con-
sumption and alcohol dependence can be similarly studied in large
population samples. Recently, such a meta-analysis of alcohol
consumption identified an SNP in the AUTS2 (autism suscepti-
bility) gene to be associated with alcohol consumption (daily
ethanol intake in g/kg body mass; P = 4.1 · 1029) (44). They also
reported significant expression differences in this gene across high
compared with low alcohol-preferring mice. More than 42,000
subjects were included in this meta-analysis, and the overall effect
size was modest. Although this is an exciting development for
genetic studies of alcohol consumption, unlike rs16969968 for
smoking, the role of AUTS2 in alcohol consumption remains to be
validated. Of course, additional loci are most likely involved in the
genetics of both alcohol and smoking.
Meta-analyses, whether epidemiologic or genetic, implicitly
require a minimum level of comparability across studies (Figure
2). Even though a meta-analysis aggregates across results from
within-study analyses, across-study heterogeneity influences the
comparability of effect sizes (eg, regression coefficients and ORs)
when there is heterogeneity in the measured endpoint. The effect
of measurement heterogeneity on gene finding is affected by
the extent to which common loci underlie the genetic contribution
to the distinct aspects of alcohol use (eg, drinking frequency,
quantity, and alcohol dependence) being meta-analyzed. In
the following sections, we discuss key contributors to hetero-
geneity in the measurement of alcohol consumption and de-
scribe their potential effect on the GWASmeta-analyses of these
phenotypes.
MEASURING ALCOHOL CONSUMPTION
Measures of alcohol consumption typically include drinking
quantity (eg, howmany drinks in a given reference period, such as
drinks/wk or drinks/d) and frequency (eg, how often one drinks in
a given reference period, such as drinking days/wk). These
FIGURE 1. Stages of alcohol involvement, the role of genetic and environmental influences, and their importance in genetic studies. The arrows indicate
the relative hypothesized magnitude of effect of genetic and environmental factors (up arrow: increasing effect, with number of arrows indicating strength of
effect; down arrow: decreasing effect). AA, Alcoholics Anonymous; CVD, cardiovascular disease.
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measures can be assessed during various reference periods: in the
past 30 d, in the past 12 mo, over a lifetime, during a period of
“typical” or “usual” alcohol consumption, or during a period of
heaviest use. Although assessed by fewer studies, differences
between drinking a certain amount of alcohol over the week or at
one sitting are also important. For example, the maximum
number of drinks consumed within a single 24-h period is also
heritable and is highly correlated with a person’s vulnerability to
excessive alcohol consumption (8, 32, 45).
WHY MEASUREMENT HETEROGENEITY OCCURS
Alcohol consumption is an aspect of normative diet, a risk factor
for a variety of health-related outcomes, and an addictive sub-
stance. Thus, depending on the goals of a study, measures of al-
cohol consumption can be collected by using food-frequency
questionnaires, from medical charts, via self-report in case-control
studies of health-related outcomes, and from interviews in studies
for addiction and other psychiatric disorders. To illustrate this
remarkable variation in the assessment of alcohol consumption,
representative alcohol-consumption measures from individual
studies of the GENEVAConsortium are shown inTable 1 (46, 47).
Within each of these realms of research, significant effort has
been made to harmonize measures of alcohol consumption. For
example, disparate measures of alcohol can be converted into
exposure categories (48), and categories of safe compared with
unsafe consumption (49) have been developed for studies of all-
cause mortality. Similar efforts have been directed at developing
harmonized alcohol-consumption measures for studies of can-
cer (50). Alcohol intake data collected by using various food-
frequency questionnaires tend to correlate highly (51, 52).
However, reducing measurement heterogeneity within a set of
studies with a common theme (eg, alcohol and cancer) does not
ensure that these alcohol measures can themselves be combined
with alcohol use assessed in studies focused on other endpoints,
ie, if one is interested in identifying the genetic underpinnings of
alcohol consumption, variations in the alcohol measures pre-
sented in Table 1 may still pose a challenge.
SOURCES OF MEASUREMENT HETEROGENEITY
The challenges associated with measurement heterogeneity for
alcohol consumption, particularly in the context of genomic
studies, are listed in Table 2. Some of these challenges are not
unique to alcohol consumption (eg, recall bias), and others are
fairly straightforward (eg, conversion of ethanol grams in a
standard drink across different countries). However, some key
concerns that are unique to alcohol consumption (eg, episodic
nature of drinking and recent abstention) can produce spurious
results because of the misclassification of subjects. Whereas we
emphasize those issues that bear major concerns for genetic
analyses, readers interested in issues related to the general
measurement of alcohol consumption are invited to read a re-
view of this topic by Dawson (53).
Interpretation of abstention
Lifetime abstainers are uncommon in several populations.
They are worth excluding from genetic studies of alcohol use and
alcohol dependence, because alcohol initiation is more strongly
affected by religious and cultural norms. Individuals with
a family history of alcoholism may also abstain from alcohol to
avoid developing the disorder, because these individuals are at
higher genetic risk. Lifetime drinkers may also report recent
abstention due to a host of environmental factors (eg, life events
and pregnancy) (54), due to health factors (eg, gastrointestinal
disease) (55), or due to enrollment in a treatment program for
alcohol dependence (eg, Alcoholics Anonymous) (56). Thus, an
individual with alcohol dependence may have susceptibility loci
for alcohol use, yet be inadvertently misclassified as a light or
nondrinker because of limitations in the design of the study in
which they participated. Studies that do not assess lifetime use are
particularly affected by this issue, because they cannot distin-
guish between lifetime and recent abstainers.
The episodic nature of alcohol consumption
Drinking, unlike smoking, is often episodic and can vary
considerably across periods of recent (past 12 mo, past 30 d, or
FIGURE 2. Stages of meta-analysis of genetic data—an illustration. ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase; GABRA2,
g-aminobutyric acid receptor subunit A2; GWAS, genome-wide association studies.
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a shorter reference period) and lifetime use (average across the
lifetime, during periods of typical or heaviest use). Even within
a single week, an individual may drink more heavily on weekends
but less frequently during the week, which produces marked
variation in their report of drinks per week. It is likely that the
magnitude and nature of genetic influences on these various
periods of drinking only partially overlap. Whereas there is
overlap across these genetic factors, this overlap diminishes when
current drinking (eg, past 30 d) is examined along with lifetime
heavy drinking (34, 57).
Quantity and frequency across reference periods
Uniform measures of alcohol consumption have not been
universally adopted. Attempts to harmonize the varying reference
periods (drinks/d, drinks/wk, or drinks/mo) used in different
studies without a measure of drinking frequency (eg, How many
days a week do you drink?) can lead to biases, particularly
because of the episodic nature of alcohol consumption. For in-
stance, assume that a study assesses drinks/d, and the respondent
reports drinking 2 drinks/d. We are interested in a measure of
drinks/wk, but we do not knowwhether the individual drinks only
on weekends. Do we compute 14 drinks/wk (2 drinks/d · 7 d),
which is a significant inflation over the accurate 4–6 drinks/wk,
or do we simply use drinks/d as the measure from that study?
Differences in cultural norms across studies
Alcohol intake varies substantially by population and is af-
fected by sex, geographic region, and cultural practices. For
example, intake among US Seventh-Day Adventists (58) varies
substantially from that among indigenous Canadian and Alaskan
native populations, such as Inuit (59–61). The substantial range in
alcohol intake across populations is another challenge when
pooling data. For example, although drinking 1 or 2 glasses of
wine per day with dinner may be very common in some pop-
ulations, it would be considered very extreme in other pop-
ulations. Thus, susceptibility loci for alcohol intake are affected
by the broader environmental context. These complicated inter-
actions are challenging to account for within the meta-analytic
framework.
Beverage forms
Considerable sociocultural and individual-specific variation in
the choice of alcoholic beverage consumed also exist, and it is
well recognized that reported alcohol consumption is higher
when participants are asked about individual beverage types
(beer, wine, and liquor) separately rather than about “alcoholic
beverages” as a group (62, 63). On the other hand, for many
alcohol-associated outcomes, such as cancer, it is thought that
ethanol is the important factor, regardless of its source. Should
measures drawn from specific alcoholic beverages be combined
with data drawn from single item assessments of “drinks”? One
possible mechanism for harmonizing these varying assessments
is via conversion to ethanol grams, which as discussed below,
requires many assumptions.
Standard drinks and conversion to ethanol grams
Although cigarettes can vary in their nicotine content, most
smokers consume cigarettes in a pack of standard size, thus
establishing a “metric” for their report. Alcohol, in contrast, is
consumed as a variety of beverages with varying ethanol con-
tents, forms (eg, mixed drinks and coolers), and quantities
(eg, can of beer and beer on tap) that render an estimate of the
number of standard drinks (ie, amount of ethanol) (64) difficult
to quantify. Drink size and ethanol content may also vary by
country. The ability to reconcile these differences by conversion
relies heavily on the participant’s understanding of the definition
of a “standard drink.” For instance, a drinker may report drinking
a glass of wine every day but drinks the wine in a large “balloon”
TABLE 2
Challenges associated with assessment of alcohol consumption from various sources
Challenge Example
Distinguishing between lifetime and recent abstention A heavy drinker recently (past 30 d) stops drinking because
of a health condition for which the study is ascertained.
Episodic nature of drinking An individual drinks 10 drinks/d on weekends but only 2
drinks/d on weekdays except during the holidays.
Individual may also report a period of risky drinking in
college but not anymore.
Reference periods for drinking can vary Because of the episodic nature of drinking, an individual
reporting consuming 3 drinks/d, on average, cannot be
assumed to be drinking 21 drinks/wk (ie, assumption that
drinking is constant every day of the week).
Cultural norms Drinking regularly may be normative in some cultures but
unacceptable in others.
Assessing different beverage forms An individual reports greater alcohol intakes when
responding to questions on beer, wine, and spirits
compared with a single question on “alcoholic drinks.”
Conversion to grams of ethanol requires participant
understanding of a “standard” drink
An individual drinks red wine at home, and unless prompted
with visual cue, it is unclear whether their pour of wine
reflects a standard pour.
Recall bias and bias attributable to other respondent
characteristics (eg, underreporting by
overweight/obese individuals)
An overweight individual reports fewer drinks because
of weight concerns.
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glass, which can contain the equivalent of 2 to 3 standard drinks;
hence, alcohol consumption and ethanol grams are underes-
timated. Picture cards or verbal/visual references of standard
drinks by beverage type (eg, beer compared with malted beer;
table wine compared with fortified wine) might be used to orient
respondents to the meaning of a standard drink. However, this
may not always be feasible within the context of a food-frequency
questionnaire.
Recall and other respondent biases
Finally, although not unique to alcohol, much like most self-
reported measures, general elements of recall bias may also
contribute to measurement inaccuracy. Recall can be biased
by characteristics correlated with drinking. For instance, un-
derweight individuals have been found to overestimate and
overweight/obese individuals tend to underreport certain aspects
of the diet (eg, fats and simple carbohydrates) (65, 66); this may
apply to alcohol consumption as well. Although statistical
approaches have been developed to address these issues, these
efforts, even if successful, can have an effect on study power.
THE FUTURE OF GWAS META-ANALYSES OF
ALCOHOL CONSUMPTION
Understanding the etiology of a behavior that is, at once, both
a feature of normal diet and a serious and common psychiatric
disorder, and a substantial cause of chronic disease, is a critical
public health issue. In this regard, it is reassuring that GWAS
meta-analyses have proven to be successful at addressing for
other complex phenotypes, including behavioral measures (67,
68). Furthermore, simulation studies suggest that, even with
exposure misclassification, very large studies can succeed at
identifying susceptibility loci (69). Importantly, if even a subset
of genetic influences is common across each alcohol metric, then
a meta-analysis should be able to identify genes contributing to
this shared genetic propensity, given a large enough data set. In
contrast, those genetic influences that are specific to particular
aspects of alcohol consumption will require careful harmoni-
zation of intake measures.
For future studies that plan on including alcohol-consumption
measures, several resources are available to guide investigators
with data collection, and they are listed in Table 3. For instance,
the PhenX Toolkit (70) offers questions on a variety of alcohol-
consumption measures, including definitions of standard drinks
as well as visual references of sizes of standard beverage
servings. PhenX also offers items to assess lifetime use, age at
first use, and symptoms of alcohol dependence for studies in-
terested in a more detailed assessment of maladaptive drinking.
The National Institute on Alcohol Abuse and Alcoholism offers
several assessments (eg, AUDIT) that can be used to screen for
and measure quantity, frequency, and liability to abuse and
dependence.
We recognize that investigators collect measures of alcohol
consumption that maximally inform their outcome of interest and
that efforts to minimize respondent burden may limit the extent to
which common assessments are used across studies. It is hoped
that the concerns raised in this review will encourage inves-
tigators to consider the inclusion of a well-validated measure that
indexes heritable variation in the tendency to drink alcohol in
their study. We recommend the inclusion of maximum drinks
consumed in a single 24-h period. This single low-burden item
was heritable (h2 = 50%) (8, 32), associated with ADH variants
(40), was found to correlate strongly with liability to alcohol
consumption and alcoholism, and may also indicate alcohol
tolerance. Even in cultures in which maximum drinks may re-
flect a “rite of passage,” such as drinking on one’s 21st birthday
in the United States, symptoms of alcohol dependence have been
found to correlate strongly even with this isolated instance of
heavy drinking (71). Undoubtedly, cultural, societal, and other
environmental factors influence this measure and its corre-
spondence with lifetime alcoholism risk. Not all individuals with
a lifetime high number of maximum drinks consumed in a single
24-h period may subsequently develop alcoholism. In detailed
assessments, indexes of quantity and frequency of drinking
augment information from maximum drinks.
Existing and ongoing studies should recognize the context of
genomic findings that arise from the combination of such hetero-
geneous sources and model random effects or calculate other metrics
of heterogeneity (see reference 72 for a review of these metrics)
when conducting genetic analyses. Even though there has been
discussion surrounding the lower power in smaller studies to detect
heterogeneity (73), this is necessary for alcohol intake. In fact, ev-
idence for between-study heterogeneity can ultimately lead to new
discoveries (eg, genes relevant only in individuals exposed to certain
environments) (74). There is often a trade-off between heterogeneity
and the sample size necessary to detect the effects of genes (69);
thus, augmenting the sample size can help. From a technical per-
spective, investigators may wish to consider statistical methods
developed for the analysis of covariates as outcomes in genomic
TABLE 3
List of resources for assessing alcohol consumption in US populations1
Resource Utility/features
https://www.phenxtoolkit.org Items to assess 30-d quantity and frequency; includes visual
aids for standard drink sizes





Items to assess risky drinking
http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm Information on standard drink sizes and some
sample questions
http://pubs.niaaa.nih.gov/publications/arh27-1/18-29.htm Discussion of measurement-related issues for alcohol (53)
1 For non-US populations, standard drink size and grams of ethanol may vary.
GENOMIC META-ANALYSIS OF ALCOHOL INTAKE STUDIES 545
studies, as is typically the case for alcohol consumption (75). Biases
in such studies are most pronounced when the primary and sec-
ondary traits are correlated with one another or if the marker jointly
influences both traits. In these instances, methods such as inverse-
probability-of-sampling weighted regression may be more appro-
priate. Many such meta-analytic efforts are currently ongoing and
are accounting for these technical caveats and amassing tens of
thousands of subjects, heralding a brand new era of discovery for the
genetics of alcohol consumption. We invite investigators with rel-
evant alcohol-related information and GWAS data to join and par-
ticipate in these ongoing efforts.
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